Frédéric Bigot
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Lung Cancer Research Studies
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 8
- COVID-19 and healthcare impacts 6
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Christophe Massard (5 shared papers)Alberto Carmona‐Bayonas (2 shared papers)Jessica Menis (1 shared paper)Eric Angevin (3 shared papers)Vincent Ribrag (2 shared papers)Jean‐Marie Michot (3 shared papers)Antoine Hollebecque (3 shared papers)Capucine Baldini (2 shared papers)
In The Last Decade
Frédéric Bigot
32 papers receiving 366 citations
Peers
Comparison fields: 5 of 58
- Oncology 183
- Cancer Research 50
- Pulmonary and Respiratory Medicine 99
- Orthopedics and Sports Medicine 13
- Surgery 63
Countries citing papers authored by Frédéric Bigot
This map shows the geographic impact of Frédéric Bigot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Bigot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Bigot more than expected).
Fields of papers citing papers by Frédéric Bigot
This network shows the impact of papers produced by Frédéric Bigot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Bigot. The network helps show where Frédéric Bigot may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Bigot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 153 | |
| 2 | 2011 | 51 | |
| 3 | 2013 | 47 | |
| 4 | 2016 | 20 | |
| 5 | 2023 | 11 | |
| 6 | 2018 | 11 | |
| 7 | 2021 | 8 | |
| 8 | 2020 | 8 | |
| 9 | 2023 | 8 | |
| 10 | 2017 | 8 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2017 | 2 |
About Frédéric Bigot
Frédéric Bigot is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 35 papers that have together received 375 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), COVID-19 and healthcare impacts (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (4 papers), Colorectal and Anal Carcinomas (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (183 citations), Cancer Research (50 citations), Pulmonary and Respiratory Medicine (99 citations), Orthopedics and Sports Medicine (13 citations) and Surgery (63 citations). Frédéric Bigot has collaborated with scholars based in France, Italy and Spain. Frequent co-authors include Christophe Massard, Alberto Carmona‐Bayonas, Jessica Menis, Eric Angevin, Vincent Ribrag, Jean‐Marie Michot, Antoine Hollebecque, Capucine Baldini, Eduardo Castañón and Sophie Postel‐Vinay. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancers, ESMO Open and International Journal of Environmental Research and Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.